D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
PUT
Allegion
ALLE
$13B
| $304K | ﹤0.01% |
+3,300
| New | +$395K |
|
|
TGH
3377
DELISTED
Textainer Group Holdings limited
TGH
| $304K | ﹤0.01% |
36,932
-103,261
| -74% | -$943K |
|
|
BSTC
3378
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $304K | ﹤0.01% |
5,369
-1,400
| -21% | -$79.8K |
|
3379
MarineMax
HZO
$800M
| $302K | ﹤0.01% |
+28,990
| New | +$472K |
|
|
SUP
3380
DELISTED
Superior Industries International
SUP
| $302K | ﹤0.01% |
251,781
-90,959
| -27% | -$240K |
|
3381
Wave Life Sciences
WVE
$1.12B
| $301K | ﹤0.01% |
32,112
+9,564
| +42% | +$81.5K |
|
|
XIFR
3382
XPLR Infrastructure LP
XIFR
$1.18B
| $301K | ﹤0.01% |
+7,000
| New | +$371K |
|
|
EBIX
3383
PUT
DELISTED
Ebix Inc
EBIX
| $301K | ﹤0.01% |
19,800
-86,200
| -81% | -$2.46M |
|
3384
Culp Inc
CULP
$45M
| $300K | ﹤0.01% |
40,770
+2,213
| +6% | +$23.9K |
|
3385
Fidus Investment
FDUS
$737M
| $300K | ﹤0.01% |
45,385
+33,273
| +275% | +$430K |
|
3386
BancFirst
BANF
$3.92B
| $299K | ﹤0.01% |
+8,974
| New | +$467K |
|
3387
XBiotech
XBIT
$69.2M
| $298K | ﹤0.01% |
28,105
-147,684
| -84% | -$2.4M |
|
3388
CALL
Travel + Leisure Co
TNL
$4.54B
| $297K | ﹤0.01% |
13,700
| – | – |
|
|
Y
3389
DELISTED
Alleghany Corp
Y
| $297K | ﹤0.01% |
537
-454
| -46% | -$327K |
|
|
BNY
3390
CALL
Bank of New York Mellon
BNY
$108B
| $296K | ﹤0.01% |
8,800
-65,100
| -88% | -$2.73M |
|
|
DX
3391
Dynex Capital
DX
$2.99B
| $296K | ﹤0.01% |
28,375
-7,646
| -21% | -$126K |
|
3392
First Merchants
FRME
$2.72B
| $296K | ﹤0.01% |
+11,162
| New | +$407K |
|
3393
Gerdau
GGB
$9.44B
| $296K | ﹤0.01% |
+195,329
| New | +$619K |
|
|
GOOD
3394
Gladstone Commercial Corp
GOOD
$627M
| $296K | ﹤0.01% |
+20,606
| New | +$392K |
|
3395
PUT
Core Laboratories
CLB
$538M
| $295K | ﹤0.01% |
28,500
+19,700
| +224% | +$551K |
|
3396
Medifast
MED
$108M
| $294K | ﹤0.01% |
+4,707
| New | +$429K |
|
|
CMA
3397
PUT
DELISTED
Comerica
CMA
| $293K | ﹤0.01% |
10,000
-12,600
| -56% | -$684K |
|
|
VNE
3398
PUT
DELISTED
Veoneer, Inc.
VNE
| $293K | ﹤0.01% |
40,000
-72,100
| -64% | -$860K |
|
3399
PUT
Centene
CNC
$31.3B
| $291K | ﹤0.01% |
4,900
-574,300
| -99% | -$34.8M |
|
|
UNVR
3400
DELISTED
Univar Solutions Inc.
UNVR
| $291K | ﹤0.01% |
+27,127
| New | +$503K |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.